Researchers To Test New Alzheimer’s Drug Targeting Inflammation in Humans
By Being Patient | April 4th, 2019
It hasn’t been a great year for Alzheimer’s drugs—or really a great decade, even. The most recent Phase 3 trial cancellation was a study…
‘There Was So Much Hope’: Biogen Trial Participants Are ‘Heartbroken’ After Cancellation
By Being Patient | March 24th, 2019
On Thursday, Biogen, along with its Japanese partner Eisai, announced it would be canceling two late-stage trials testing their drug aducanumab. The drug was…
A Late-Stage Alzheimer’s Trial Gave Them Hope—Until It Was Canceled
By Being Patient | March 22nd, 2019
A Late-Stage Alzheimer's Trial Gave Them Hope—Until It Was CanceledWatch this video on YouTube Jeff Borghoff and his wife Kimberly speak about participating in…
Dementia Deaths Have More Than Doubled, According to Report. Here’s What Can Be Done
By Being Patient | March 15th, 2019
Dementia is steadily rising in the ranks of causes of death in America, according to a new report released by the National Center for…
F.D.A. Gives Warning for Young Blood Treatment for Aging and Alzheimer’s
By Being Patient | February 19th, 2019
It sounds like something out of a science fiction movie with a Goop-esque twist: a company called Ambrosia offers plasma transfusions of “young” blood into…
Follow us